PPT-Optimizing Mobile Clinical Trials by Engaging Patients and Sites

Leanne Madre CTTI Cindy Geoghegan Individual Patient Representative Virginia Nido Genentech a Member of the Roche Group February 21 2019 Disclaimer The views and opinions expressed in this presentation are those of the individual presenter and do not necessarily reflect the views of the Clinical Trials Transformation Initiative. Anh Ninh, College of William and Mary. Outline. Introduction. The Inventory Positioning Problem. Description of the problem. Unique features. Basic of inventory management. Site Selection Problem. 2. Anh Ninh, College of William and Mary. Outline. Introduction. The Inventory Positioning Problem. Description of the problem. Unique features. Basic of inventory management. Site Selection Problem. 2. Industry and CRO Perspective on Clinical Trial Quality David J. Hewitt Vice President of Medical and Scientific Affairs Vice President and Global Head MSA Neurology and Pain IMMPACT June 2015 Currently working for inVentiv Health a CRO/CCO Virginia A. Caine, M.D.. Associate Professor of Medicine. Division of Infectious Diseases. Indiana University School of Medicine. Director, Marion County Public Health Department. Indianapolis, Indiana. Generated by Mobile Technology for . Use in Clinical Trials*. *The term “clinical trial” is used here to refer to studies done to support regulatory approval for marketing. . Source: Clinical Trials Transformation Initiative’s . 617TRIALS FOR RELAPSED/REFRACTORY PATIENTS19-021p 2A phase 1/2 study of oral LOXO-305 in patients with previously-treated chronic ymphocytic progression or discontinuation for adverse event18-719p 3A Module 3: The Basics of Health Care. Oncology Patient Navigator Training: The Fundamentals. Acknowledgements. This work was supported by Cooperative Agreement #1U38DP004972-02 from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.. Ashley E. Ross MD PhD. Executive Medical Director. Mary Crowley Cancer Research Centers. NASPCC Annual Meeting 2019. Objectives. Define GCP (Good Clinical Practice) and its applications for patients and research.. new evidence to improve patient . care. Dr . Isla Mackenzie. Clinical . Reader in Clinical Pharmacology. Medicines Monitoring Unit (MEMO). University of Dundee. Clinical pharmacologists lead clinical trials that change practice. This webinar is being recorded and will be posted to the CTTI website. All participants are muted upon entry. Questions can be entered in the chat box during the webinar . Questions will be . addressed after . Joint Recommendations of the American Society of Clinical Oncology and Friends of Cancer Research. October 2, 2017. What . is the goal. ?. Challenge assumptions & past practice. Create new culture – only exclude where safety warrants. This webinar is being recorded and will be posted to the CTTI website. All participants are muted upon entry. Questions can be entered in the chat box during the webinar. Questions will be answered to the best of our ability after the call via CTTI’s best practices document. Birthe Lemley. Executive. Board . Member. of ENGAGe. President. of KIU – Danish Patient Organisation for . Women. with . Gynaecological. Cancer. Board Member of EUPATI, Denmark. What. . is. a Clinical Trial?. Tim Morris. MRC Clinical Trials Unit at UCL. 14 May 2018 | International Clinical Trials Day. Re-randomisation design. Definition. :. Patients . who have previously participated . may . be re-entered into a .